作为抗微生物协同剂的菌体衍生脱聚酶:克服耐药性的策略
Shuhong Han1,2,3, David H Yang4, Jiayin Shen1,2,3
1National Clinical Research Center for Infectious Diseases, The Third People's Hospital of Shenzhen and The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen, Guangdong, China.
Bioscience trends
|February 8, 2026
概括
细菌的多糖屏障,如CPS,EPS和LPS燃料抗微生物耐药性. 由细菌体进化出来的脱聚酶会降解这些屏障,增强抗生素和菌体治疗的疗效.
科学领域:
- 微生物学 微生物学
- 生物技术是生物技术.
- 药物发现 药物发现 药物发现
背景情况:
- 细菌利用多糖层 (CPS,EPS,LPS) 作为保护屏障.
- 这些障碍物阻碍了抗生素扩散和宿主免疫反应,导致抗菌素耐药性.
- 菌体拥有去聚合酶酶,可以降解细菌的多糖体结构.
研究的目的:
- 审查作为现有抗微生物策略的辅助剂的脱聚酶的治疗潜力.
- 评估脱聚酶增强抗生素疗效和菌体治疗的能力.
- 探索基于脱聚合酶的治疗方法的进化动态和临床翻译挑战.
主要方法:
- 对脱聚合酶功能和应用的系统文献综述.
- 在降解细菌多糖体中的脱聚合酶机制的分析.
- 整合进化生物学原理来预测耐药性发展.
主要成果:
- 脱聚酶在提高抗生素透率和有效性方面显示出显著的前景.
- 菌体治疗的疗效可以通过同时使用脱聚合酶来提高.
- 了解细菌对脱聚酶的适应性反应对于持续的治疗成功至关重要.
结论:
- 脱聚酶是一种有价值的协同方法,用于打击抗菌素耐药性.
- 对脱聚合酶翻译的配方和临床应用需要进一步的研究.
- 基于脱聚合酶的疗法为克服细菌防御机制提供了一个有希望的途径.
相关概念视频
Lysogenic Cycle of Bacteriophages
68.0K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
68.0K
Lytic Cycle of Bacteriophages
78.2K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
78.2K
DNA Bacteriophages
1.0K
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
1.0K
Antimicrobial Effectiveness
1.0K
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
1.0K
Antimicrobial Proteins
14.5K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
14.5K
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
212
Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
212


